A Genetic Mouse Model Showed Faster Tolerance to Some Cannabinoid Effects but Persistent Anxiety-Like Responses
Faster tolerance to movement or temperature effects did not mean faster tolerance to anxiety-like effects in a neuregulin-1 mouse model. The same treatment history produced different adaptation patterns across outcomes.
The experiment used an altered gene and synthetic agonist
Researchers compared Nrg1 heterozygous and wild-type mice during repeated CP55,940 exposure. They measured locomotion, body temperature, anxiety-related behavior, prepulse inhibition and selected brain-protein markers.
The behavioral findings diverged
The altered-gene mice developed tolerance to hypothermia and movement suppression more rapidly. In the light-dark test, however, they maintained marked anxiety-like responses while wild-type animals developed tolerance across testing.
A susceptibility model is not a diagnosis
The gene's relationship to schizophrenia research does not mean every altered-gene mouse has human schizophrenia, or that a person's genotype predicts their cannabis response. The experimental compound also should not be treated as an identical exposure to THC.
Prepulse-inhibition and startle findings added further endpoint-specific variation. None of these measures supplies a direct clinical symptom assessment or a driving test. The study demonstrates why a single label such as cannabinoid tolerant is too broad: temperature, activity, anxiety-like behavior and sensory-processing measures can adapt differently within the same biological model.
Related: interpreting cannabis tolerance claims.
Research cited
Boucher AA; Hunt GE; Micheau J; Huang X; McGregor IS; Karl T; Arnold JC. The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. The international journal of neuropsychopharmacology (2011). doi:10.1017/S146114571000091X. Findings discussed from the study abstract.
